Coronary Artery Bypass Graft in the Treatment of Severe is Chemic Cardiomyopathy

胡盛寿,张怀军,吴清玉,朱晓东,许建屏
DOI: https://doi.org/10.3760/cma.j.issn.1001-4497.2000.06.005
2000-01-01
Abstract:Objective To evaluate the effect of coronary artery bypass graft(CABG) in the treatment of severe ischemic cardiomyopathy. Method 44 patients with severe ischemic cardiomyopathy, isolated LVEF less than 35% received CABG. Average LVEF was 30 2%±7 5%. Mean LVEDD was (61 5±10 6)?mm. The presence of living myocardium in the area of ischemia was PET. An average of 2 5 grafts was performed per patient. Result One patient died from ventricular arrhythmia fourth day postoperatively. IABP was used in four patients. The mean follow up interval was 42 5 months. LVEF was significantly increased (49 5%±10 6%,P0 05) and LVEDD was decreased to 59 6?mm(P0 05) postoperatively. Conclusion The effect of CABG in severe ischemic cardiomyopathy depends on the amount of living myocardium present. It is important to control hypertension and diabetes before CABG. IABP should be applied early when weanning from pump is difficult.
What problem does this paper attempt to address?